Healthcare industry lobbyists who are used to exerting significant influence over legislation and committee activity in Washington, D.C. are fretting that they may see their sway diminish after Sen. Bernie Sanders — a vocal opponent of K Street’s outsized power — takes over the Senate’s top health panel in the new Congress. Politico reported Tuesday that “multiple lobbyists representing health…
